Ampio Pharmaceuticals reports 2017 executive compensation

CEO Michael Macaluso receives $573K

Ampio Pharmaceuticals reported fiscal year 2017 executive compensation information on October 31, 2018.

In 2017, five executives at Ampio Pharmaceuticals received on average a compensation package of $357,404, a 34% increase compared to previous year.

Average pay of disclosed executives at Ampio Pharmaceuticals

Michael Macaluso, Chief Executive Officer, received $573,016 in total, which increased by 88% compared to 2016. 52.35% of Macaluso's compensation, or $300,000, was in salary. Macaluso also received $5,000 in bonus and $268,016 in option awards.

Thomas E. Chilcott, Chief Financial Officer, received a compensation package of $391,844. 43.48% of the compensation package, or $170,386, was in option awards.

David Bar-Or, Chief Scientific Officer, earned $351,728 in 2017, a 15% increase compared to previous year.

Holli Cherevka, Chief Operating Officer effective September, received $324,082 in 2017.

Gregory A. Gould, Chief Financial Officer, earned $146,351 in 2017, a 62% decrease compared to previous year.